![](/img/cover-not-exists.png)
Development and validation of two screening assays for the HCV NS3 Q80K polymorphism associated with reduced response to combination treatment regimens containing simeprevir
Chui, C. K. S., Dong, W. W. Y., Joy, J. B., Poon, A. F. Y., Dong, W. Y., Mo, T, Woods, C. K., Beatty, C, Hew, H, Harrigan, P. R., Brumme, C. J.Language:
english
Journal:
Journal of Clinical Microbiology
DOI:
10.1128/jcm.00650-15
Date:
July, 2015
File:
PDF, 707 KB
english, 2015